These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 16364651

  • 21. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
    Shimizu T, Tanaka K, Shimizu S, Higashi Y, Yawata T, Nakamura K, Taniuchi K, Ueba T, Yuri K, Saito M.
    Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
    [Abstract] [Full Text] [Related]

  • 22. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
    Rockwell CE, Snider NT, Thompson JT, Vanden Heuvel JP, Kaminski NE.
    Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
    [Abstract] [Full Text] [Related]

  • 23. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.
    Siegmund SV, Wojtalla A, Schlosser M, Zimmer A, Singer MV.
    Biochem Biophys Res Commun; 2013 Jul 19; 437(1):48-54. PubMed ID: 23806692
    [Abstract] [Full Text] [Related]

  • 24. The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.
    Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E.
    Neurobiol Dis; 2010 May 19; 38(2):304-12. PubMed ID: 20156559
    [Abstract] [Full Text] [Related]

  • 25. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
    Kim J, Watkins BA.
    J Nutr Biochem; 2014 Aug 19; 25(8):815-23. PubMed ID: 24854955
    [Abstract] [Full Text] [Related]

  • 26. Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat.
    Trembovler V, Beit-Yannai E, Younis F, Gallily R, Horowitz M, Shohami E.
    J Interferon Cytokine Res; 1999 Jul 19; 19(7):791-5. PubMed ID: 10454350
    [Abstract] [Full Text] [Related]

  • 27. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M.
    Neuroscience; 2009 Sep 29; 163(1):456-65. PubMed ID: 19524019
    [Abstract] [Full Text] [Related]

  • 28. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1.
    Beni SM, Kohen R, Reiter RJ, Tan DX, Shohami E.
    FASEB J; 2004 Jan 29; 18(1):149-51. PubMed ID: 14597558
    [Abstract] [Full Text] [Related]

  • 29. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T, Ueno S, Obara Y, Nakahata N.
    J Pharm Pharmacol; 2011 May 29; 63(5):636-47. PubMed ID: 21492165
    [Abstract] [Full Text] [Related]

  • 30. Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia.
    Zhu Y, Saito K, Murakami Y, Asano M, Iwakura Y, Seishima M.
    Neurosci Lett; 2006 Jan 30; 393(2-3):122-6. PubMed ID: 16356636
    [Abstract] [Full Text] [Related]

  • 31. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle.
    Lang CH, Silvis C, Deshpande N, Nystrom G, Frost RA.
    Shock; 2003 Jun 30; 19(6):538-46. PubMed ID: 12785009
    [Abstract] [Full Text] [Related]

  • 32. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.
    Suplita RL, Gutierrez T, Fegley D, Piomelli D, Hohmann AG.
    Neuropharmacology; 2006 Mar 30; 50(3):372-9. PubMed ID: 16316669
    [Abstract] [Full Text] [Related]

  • 33. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.
    Kaplan BL, Ouyang Y, Rockwell CE, Rao GK, Kaminski NE.
    J Leukoc Biol; 2005 Jun 30; 77(6):966-74. PubMed ID: 15774549
    [Abstract] [Full Text] [Related]

  • 34. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
    Rea K, Ford GK, Olango WM, Harhen B, Roche M, Finn DP.
    Eur J Neurosci; 2014 Feb 30; 39(3):435-43. PubMed ID: 24494683
    [Abstract] [Full Text] [Related]

  • 35. Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity.
    Sido JM, Nagarkatti PS, Nagarkatti M.
    Eur J Immunol; 2016 Jun 30; 46(6):1472-9. PubMed ID: 27064137
    [Abstract] [Full Text] [Related]

  • 36. A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells.
    Rockwell CE, Raman P, Kaplan BL, Kaminski NE.
    Biochem Pharmacol; 2008 Aug 01; 76(3):353-61. PubMed ID: 18571623
    [Abstract] [Full Text] [Related]

  • 37. Posttraumatic administration of luteolin protects mice from traumatic brain injury: implication of autophagy and inflammation.
    Xu J, Wang H, Lu X, Ding K, Zhang L, He J, Wei W, Wu Y.
    Brain Res; 2014 Sep 25; 1582():237-46. PubMed ID: 25093609
    [Abstract] [Full Text] [Related]

  • 38. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
    Szekeres M, Nádasy GL, Turu G, Soltész-Katona E, Benyó Z, Offermanns S, Ruisanchez É, Szabó E, Takáts Z, Bátkai S, Tóth ZE, Hunyady L.
    Mol Cell Endocrinol; 2015 Mar 05; 403():46-56. PubMed ID: 25595485
    [Abstract] [Full Text] [Related]

  • 39. Neuroscience. Stout guards of the central nervous system.
    Mechoulam R, Lichtman AH.
    Science; 2003 Oct 03; 302(5642):65-7. PubMed ID: 14526067
    [Abstract] [Full Text] [Related]

  • 40. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury.
    Wang PF, Jiang LS, Bu J, Huang XJ, Song W, Du YP, He B.
    J Cardiovasc Pharmacol; 2012 Apr 03; 59(4):301-7. PubMed ID: 22113346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.